Drugs / DA-5219
last change Jul 2025 re-read 2 minutes ago

DA-5219

Developed for
chronic gastritis
Investigated by
Dong-A ST Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT06151210 Jan 2024 → Jul 2025 chronic gastritis Dong-A ST Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DA-5219 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06151210